Prevention of lymphoedema after clearance by external compressio
- Conditions
- Topic: National Cancer Research NetworkSubtopic: Breast CancerDisease: BreastCancerBreast cancer
- Registration Number
- ISRCTN92355292
- Lead Sponsor
- niversity Hospital of South Manchester (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 270
1. Women aged 18 - 90 years
2. Early breast cancer (no evidence of metastatic disease by local screening procedures), scheduled to undergo axillary node clearance
3. Consented to pre-surgical arm measurements by perometer and develop arm volume increases of 4 - 8.9% within 6 months after surgery
4. Willing to attend for follow-up visits per the trial schedule
5. Written informed consent to enter the PLACE trial
1. Any patients with no pre-surgical baseline measurements
2. Known distant metastasis
3. Inoperable breast cancer (T4 category or distant metastasis)
4. Node negative not undergoing axillary clearance
5. Previous axillary radiotherapy
6. Past history of breast/chest wall radiotherapy
7. Previous axillary clearance, either unilateral or bilateral
8. Participation in another clinical trial of local therapy that may affect the results obtained in this study
9. Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method